James Neal's Trading History
| PCSAProcessa Pharmaceuticals | Jun 30, 2026 | Director | Uninformative Buy | 377.58 | $1.93K | |
| AKTXAkari Therapeutics | Mar 10, 2025 | Director | Uninformative Buy | 5.00K | $298.87K | |
| PKBOPeak Bio | Nov 18, 2024 | ― | Uninformative Sell | ― | $0.00 | |
| PALIPalisade Bio | Feb 13, 2024 | Director | Uninformative Buy | 4.80K | $12.67K | |
| XOMAXOMA Royalty Corporation | Jul 18, 2022 | ― | Uninformative Buy | 100.75K | $1.34M |
You May Also Like
James Neal insider profile FAQ
What is the percentage of profitable transactions made by James Neal?
The percentage of profitable transactions made by James Neal is 87%.
What is the average return per transaction made by James Neal?
The average return per transaction made by James Neal is 47.10%.
What stocks does James Neal hold?
James Neal holds: PCSA, PALI, XOMA, AKTX, PKBO stocks.
What was James Neal’s latest transaction?
James Neal’s latest transaction was an Uninformative Buy of $377.58.
What was James Neal's most profitable transaction?
James Neal’s most profitable transaction was an Informative Buy of XOMA stock on December 21, 2018. The return on the trade was 116.00%.
What is James Neal's role in Processa Pharmaceuticals?
James Neal's role in Processa Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.